BELLUS Health Inc Stock Toronto S.E.
Equities
CA07987C1059
Biotechnology & Medical Research
Sales 2021 | 16K 11.63K | Sales 2022 | 16K 11.63K | Capitalization | 1.03B 752M |
---|---|---|---|---|---|
Net income 2021 | -71M -51.61M | Net income 2022 | -76M -55.24M | EV / Sales 2021 | 36,461 x |
Net cash position 2021 | 248M 180M | Net cash position 2022 | 336M 244M | EV / Sales 2022 | 43,652 x |
P/E ratio 2021 |
-8.96
x | P/E ratio 2022 |
-12.4
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 81.52% |
Managers | Title | Age | Since |
---|---|---|---|
Roberto Bellini
CEO | Chief Executive Officer | 44 | 09-06-04 |
Jeremy Martin
PSD | President | - | - |
Chairman | 77 | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 77 | 01-12-31 | |
Franklin Berger
BRD | Director/Board Member | 74 | 10-04-30 |
Director/Board Member | 52 | 09-05-31 |
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |